Format

Send to

Choose Destination
Clin Microbiol Infect. 2015 Dec;21(12):1057-66. doi: 10.1016/j.cmi.2015.09.021. Epub 2015 Oct 3.

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries.

Author information

1
Imperial College Healthcare NHS Trust, London, UK. Electronic address: jon.otter@imperial.nhs.uk.
2
Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, Germany.
3
Division of Infectious Diseases, Department of Internal Medicine I, Tübingen University Hospital, Tübingen, Germany.
4
Department of Internal Medicine, Infectious Diseases Unit, University Hospital of Heraklion, Heraklion, Crete, Greece.
5
Imperial College Healthcare NHS Trust, London, UK; Imperial College London, UK.

Abstract

The various guidelines that are available for multidrug-resistant Gram-negative bacteria are useful, and contain broad areas of agreement. However, there are also important areas of controversy between the guidelines in terms of the details of applying contact precautions, single-room isolation and active surveillance cultures, differences in the approach to environmental cleaning and disinfection, and whether or not to perform staff and patient cohorting, healthcare worker screening or patient decolonization. The evidence-base is extremely limited and further research is urgently required to inform an evidence-based approach to multidrug-resistant Gram-negative bacteria prevention and control.

KEYWORDS:

Acinetobacter; Klebsiella; guidelines; infection control; multidrug-resistant Gram-negative bacteria

PMID:
26435462
DOI:
10.1016/j.cmi.2015.09.021
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center